News
Gemini, the crypto exchange founded by the Winklevoss twins, has filed to list on Nasdaq despite a $282 million loss, aiming ...
Bitcoin (CRYPTO: BTC) critic and economist Peter Schiff issued warnings on Friday about America’s mounting debt crisis, ...
Tesla Senior Vice President Tom Zhu has sold over 82% of his shares since 2023, raising concerns about insider confidence amid Elon Musk's attacks on short sellers.
Trump and Putin's Alaska summit ended without a Ukraine ceasefire deal, giving Moscow a diplomatic boost but leaving the war's core disputes unresolved.
OpenAI CEO Sam Altman has secured a new partnership with the U.S. General Services Administration that will give federal ...
Buying $100 In BIDU: If an investor had bought $100 of BIDU stock 20 years ago, it would be worth $2,472.14 today based on a price of $89.85 for BIDU at the time of writing.
Buying $1000 In CIEN: If an investor had bought $1000 of CIEN stock 15 years ago, it would be worth $7,223.37 today based on a price of $90.87 for CIEN at the time of writing.
AI companies are raising follow-on rounds in just 6–12 months, rapidly boosting valuations that typically take years to grow.
The reel opens with a relatable clip: actor Rainn Wilson griping that he received a one-star review from an Airbnb ABNB +0.16 ...
Sticky inflation be damned. Investors expect the Federal Reserve to cut interest rates by a quarter of a percentage point in ...
Gorky Urquieta, managing director and global co-head of emerging markets debt at Neuberger Berman, said, “We think that the ...
Pfizer's Phase 3 trial of inclacumab in sickle cell disease misses its main goal but shows safety, with further updates on other drugs planned.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results